{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:12:06Z","timestamp":1772637126236,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","award":["QUEST20PE0"],"award-info":[{"award-number":["QUEST20PE0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","award":["SAWICK14PE1"],"award-info":[{"award-number":["SAWICK14PE1"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","award":["RIEKER15PE0"],"award-info":[{"award-number":["RIEKER15PE0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cct.2024.107752","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T17:24:39Z","timestamp":1731864279000},"page":"107752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study"],"prefix":"10.1016","volume":"148","author":[{"given":"Jill","family":"Maggs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Sawicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callie","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Yablon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Ertman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin S.","family":"Everhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Prickett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex H.","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Mayer-Hamblett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tia","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin A.","family":"Riekert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.cct.2024.107752_bb0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2702.2009.03041.x","article-title":"Clinical trials: the challenge of recruitment and retention of participants","volume":"19","author":"Gul","year":"2010","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.cct.2024.107752_bb0015","series-title":"CFF Patient Registry Annual Data Report [Internet]","year":"2022"},{"issue":"1","key":"10.1016\/j.cct.2024.107752_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02739610701766859","article-title":"The cystic fibrosis foundation therapeutics development network: a national effort by the cystic fibrosis foundation to build a clinical trials network","volume":"37","author":"Goss","year":"2008","journal-title":"Child. Health Care"},{"issue":"11","key":"10.1016\/j.cct.2024.107752_bb0025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0169-409X(02)00163-1","article-title":"The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases","volume":"54","author":"Goss","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cct.2024.107752_bb0030","series-title":"Trailblazer Clinical Trials One_Pager 2017.Pdf","year":"2017"},{"issue":"10212","key":"10.1016\/j.cct.2024.107752_bb0035","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cct.2024.107752_bb0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.cct.2024.107752_bb0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2018.11.010","article-title":"Beyond the expected: identifying broad research priorities of researchers and the cystic fibrosis community","volume":"18","author":"Hollin","year":"2019","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.cct.2024.107752_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S2213-2600(22)00434-9","article-title":"Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials","volume":"11","author":"Mayer-Hamblett","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.cct.2024.107752_bb0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jcf.2019.11.007","article-title":"Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy","volume":"19","author":"Gifford","year":"2020","journal-title":"J. Cyst. Fibros."},{"issue":"8","key":"10.1016\/j.cct.2024.107752_bb0060","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1513\/AnnalsATS.202010-1336SD","article-title":"Evaluating the impact of stopping chronic therapies after modulator drug therapy in cystic fibrosis: the SIMPLIFY clinical trial study design","volume":"18","author":"Mayer-Hamblett","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"3","key":"10.1016\/j.cct.2024.107752_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.qai.0000152039.88422.ec","article-title":"Motivations for participating in an HIV vaccine efficacy trial","volume":"39","author":"Colfax","year":"2005","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.cct.2024.107752_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.conctc.2017.05.007","article-title":"Reasons for participating in a randomised clinical trial: the volunteers\u2019 voices in the COSTOP trial in Uganda","volume":"7","author":"Ssali","year":"2017","journal-title":"Contemp Clin Trials Commun."},{"issue":"5","key":"10.1016\/j.cct.2024.107752_bb0075","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jcf.2023.04.015","article-title":"Partners in research: the success with therapies research consortium and the CF community unite to improve self-management","volume":"22","author":"Sawicki","year":"2023","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.cct.2024.107752_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International J. Qual. Health Care"},{"issue":"1","key":"10.1016\/j.cct.2024.107752_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: an experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"10.1016\/j.cct.2024.107752_bb0090","series-title":"Qualitative inquiry and research design: choosing among five approaches","first-page":"147","author":"Creswell","year":"2018"},{"issue":"5","key":"10.1016\/j.cct.2024.107752_bb0095","doi-asserted-by":"crossref","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","article-title":"A simple method to assess and report thematic saturation in qualitative research. Soundy A, editor","volume":"15","author":"Guest","year":"2020","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.cct.2024.107752_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/S40037-019-0509-2","article-title":"How phenomenology can help us learn from the experiences of others","volume":"8","author":"Neubauer","year":"2019","journal-title":"Perspect Med Educ."},{"issue":"4","key":"10.1016\/j.cct.2024.107752_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/17407745211011068","article-title":"Strategies for research participant engagement: a synthetic review and conceptual framework","volume":"18","author":"Wong","year":"2021","journal-title":"Clin. Trials"},{"issue":"6","key":"10.1016\/j.cct.2024.107752_bb0110","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1111\/bcp.15205","article-title":"A systematic review of methods used to conduct decentralised clinical trials","volume":"88","author":"Rogers","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2024.107752_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jclinepi.2021.01.014","article-title":"Transparency, trust and minimizing burden to increase recruitment and retention in trials: a systematic review","volume":"134","author":"Natale","year":"2021","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.cct.2024.107752_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcf.2020.12.007","article-title":"The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network","volume":"20","author":"Pearson","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.cct.2024.107752_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcf.2023.04.024","article-title":"A discrete choice experiment to quantify the influence of trial features on the decision to participate in cystic fibrosis trials","volume":"23","author":"Dobra","year":"2024","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.cct.2024.107752_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13063-018-2535-5","article-title":"Trial forge guidance 1: what is a study within a trial (SWAT)?","volume":"19","author":"Treweek","year":"2018","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.cct.2024.107752_bb0135","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.2105\/AJPH.2013.301706","article-title":"A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific islanders","volume":"104","author":"George","year":"2014","journal-title":"Am. J. Public Health"},{"issue":"3","key":"10.1016\/j.cct.2024.107752_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1353\/hpu.0.0323","article-title":"More than Tuskegee: understanding mistrust about research participation","volume":"21","author":"Scharff","year":"2010","journal-title":"J. Health Care Poor Underserved"},{"issue":"3","key":"10.1016\/j.cct.2024.107752_bb0145","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202105-1210ST","article-title":"Enhancing recruitment and retention of minority populations for clinical research in pulmonary, critical care, and sleep medicine: an official American thoracic society research statement","volume":"204","author":"Thakur","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:27:02Z","timestamp":1736303222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714424003355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"alternative-id":["S1551714424003355"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2024.107752","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2024.107752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107752"}}